Search Results - "Ho, R L"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma by Liu, L-p, Hu, B-g, Ye, C, Ho, R L K, Chen, G G, Lai, P B S

    Published in British journal of cancer (18-02-2014)
    “…Background: Mutations in HBx gene are frequently found in HBV-associated hepatocellular carcinoma (HCC). Activation of hypoxia-inducible factor-1 α (HIF-1 α )…”
    Get full text
    Journal Article
  2. 2

    Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma by Cheng, Y, Ho, R L K Y, Chan, K C, Kan, R, Tung, E, Lung, H L, Yau, W L, Cheung, A K L, Ko, J M Y, Zhang, Z F, Luo, D Z, Feng, Z B, Chen, S, Guan, X Y, Kwong, D, Stanbridge, E J, Lung, M L

    Published in Oncogene (06-08-2015)
    “…Zinc-finger, MYND-type containing 10 ( ZMYND10 ), or more commonly called BLU, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and…”
    Get full text
    Journal Article
  3. 3

    Systems Biology: An Evolving Approach in Drug Discovery and Development by Ho, R. L., Lieu, C. A.

    Published in Drugs in R&D (01-01-2008)
    “…Investments in systems biology approaches by the pharmaceutical industry have not yet yielded the payoffs envisaged by many. In most cases, a plethora of novel…”
    Get full text
    Journal Article
  4. 4

    Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC) by Chen, G.G, Ho, R.L.K, Wong, J, Lee, K.F, Lai, P.B.S

    Published in European journal of surgical oncology (01-09-2007)
    “…Abstract Background Variations of serum AFP levels in HCC patients and cell lines are likely due to the differential activity of enhancer/silencer elements…”
    Get full text
    Journal Article
  5. 5

    Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma : A prospective randomized trial by KA LAU LEUNG, LAI, P. B. S, HO, R. L. K, MENG, W. C. S, YIU, R. Y. C, LEE, J. F. Y, WAN YEE LAU

    Published in Annals of surgery (01-04-2000)
    “…To compare the systemic cytokine response in patients after laparoscopic-assisted resection with those after open resection of rectosigmoid carcinoma…”
    Get full text
    Journal Article
  6. 6

    Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma by Chen, G.G., Li, M.Y., Ho, R.L.K., Chak, E.C.W., Lau, W.Y., Lai, P.B.S.

    Published in Journal of clinical virology (01-09-2005)
    “…Chronic infection by hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC) in man. The viral transactivator HBV X (HBx) gene plays a…”
    Get full text
    Journal Article
  7. 7

    Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein by Chen, G.G., Lai, P.B.S., Chan, P.K.S., Chak, E.C.W., Yip, J.H.Y., Ho, R.L.K., Leung, B.C.S., Lau, W.Y.

    Published in European journal of cancer (1990) (01-09-2001)
    “…As a mitochondrial membrane death ligand, Bid oligomerises Bak to release cytochrome C and its deficiency renders hepatocytes resistant to apoptosis induced by…”
    Get full text
    Journal Article
  8. 8

    PROSPECTIVE RANDOMIZED CONTROL STUDY ON THE EFFECT OF BRANCHED-CHAIN AMINO ACIDS IN PATIENTS WITH LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA by Meng, W. C. S., Leung, K. L., Ho, R. L. K., Leung, T. W. T., Lau, W. Y.

    “…Background: Aminoleban EN contains branched‐chain amino acids (BCAA) and is known to be beneficial for the protein‐energy malnutrition in cirrhotic patients…”
    Get full text
    Journal Article
  9. 9

    HBx mutants differentially affect the activation of hypoxia-inducible factor-1[alpha] in hepatocellular carcinoma by Liu, L-p, Hu, B-g, Ye, C, Ho, R L K, Chen, G G, Lai, P B S

    Published in British journal of cancer (18-02-2014)
    “…Mutations in HBx gene are frequently found in HBV-associated hepatocellular carcinoma (HCC). Activation of hypoxia-inducible factor-1α (HIF-1α) contributes to…”
    Get full text
    Journal Article
  10. 10

    Adriamycin-induced modulation of host defenses in tumor-bearing mice by MACCUBBIN, D. L, WING, K. R, MACE, K. F, HO, R. L. X, EHRKE, M. J, MIHICH, E

    Published in Cancer research (Chicago, Ill.) (01-07-1992)
    “…Using the C57BL/6/EL4 tumor model, studies were carried out to demonstrate the feasibility of administering Adriamycin (ADM) in therapeutic doses and schedules…”
    Get full text
    Journal Article
  11. 11

    Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2 by EHRKE, M. J, VERSTOVSEK, S, ZALESKIS, G, HO, R. L. X, UJHAZY, P, MACCUBBIN, D. L, MIHICH, E

    Published in Cancer Immunology, Immunotherapy (01-05-1996)
    “…This laboratory has reported the conditions for an effective, non-toxic, chemoimmunotherapy utilizing doxorubicin in combination with prolonged administration…”
    Get full text
    Journal Article
  12. 12

    Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin-sensitive and -resistant lymphomas by Ho, R L, Maccubbin, D, Zaleskis, G, Krawczyk, C, Wing, K, Mihich, E, Ehrke, M J

    Published in Oncology research (1993)
    “…This laboratory has extensively studied Adriamycin (doxorubicin)-induced immunomodulation. Despite demonstration of favorable effects, little therapeutic…”
    Get more information
    Journal Article
  13. 13

    Species-specific TNF induction of thymocyte proliferation by EHRKE, M. J, HO, R. L. X, HORI, K

    Published in Cancer Immunology Immunotherapy (01-09-1988)
    “…Recombinant murine (rMu) tumor necrosis factor (TNF), in a standard comitogenic assay with phytohemagglutinin, induced murine thymocyte proliferation, while up…”
    Get full text
    Journal Article
  14. 14

    Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study by Zaleskis, G, Ho, R L, Diegelman, P, Maccubbin, D, Ujházy, P, Mihich, E, Ehrke, M J

    Published in Oncology research (1994)
    “…Recently we have reported the development of a safe and effective chemoimmunotherapy protocol involving doxorubicin (Dox) in combination with interleukin 2…”
    Get more information
    Journal Article
  15. 15

    Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma by Ho, R L, Maccubbin, D L, Ujházy, P, Zaleskis, G, Eppolito, C, Mihich, E, Ehrke, M J

    Published in Oncology research (1993)
    “…A safe and effective therapeutic combination of moderate doses of Adriamycin (doxorubicin, 4 mg/kg, IV, Days 1 and 8 or only Day 8) plus prolonged…”
    Get more information
    Journal Article
  16. 16

    Pentaglobin in steroid-resistant severe acute respiratory syndrome by HO, J. C, WU, A. Y, TSANG, K. W, LAM, B, OOI, G. C, KHONG, P-L, HO, P. L, CHAN-YEUNG, M, ZHONG, N-S, KO, C, LAM, W. K

    “…SETTING: The treatment of severe acute respiratory syndrome (SARS) is at best controversial, although there is considerable anecdotal experience to show the…”
    Get full text
    Journal Article
  17. 17

    Effects of a Care Protocol on Care Outcomes in Older Nursing Home Patients with Chronic Obstructive Pulmonary Disease by Lee, Diana T. F., Lee, Iris F. K., Mackenzie, Ann E., Ho, Rosalie N. L.

    “…OBJECTIVES: To evaluate the effects of a care protocol used by community nurses to support nursing home staff in the care of patients with chronic obstructive…”
    Get full text
    Journal Article
  18. 18

    An audio watermarking algorithm based on significant component modulation by Yi-Lun Ho, Hsiao-Chuan Wang

    “…Digital watermarking which hides the binary information in the digital multimedia files is an effective method for copyright protection. We propose a new…”
    Get full text
    Conference Proceeding
  19. 19

    The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model by Ujhazy, P, Chen, Y F, Fredericks, W, Ho, R L, Mihich, E, Baker, R M, Ehrke, M J

    Published in Cancer communications (New York) (1990)
    “…A number of recent studies have implied that a relationship exists between cellular sensitivities to tumor necrosis factor (TNF) and expression of the classic…”
    Get more information
    Journal Article